SG11202101290SA - Novel mutations that enhance the dna cleavage activity of acidaminococcus sp. cpf1 - Google Patents
Novel mutations that enhance the dna cleavage activity of acidaminococcus sp. cpf1Info
- Publication number
- SG11202101290SA SG11202101290SA SG11202101290SA SG11202101290SA SG11202101290SA SG 11202101290S A SG11202101290S A SG 11202101290SA SG 11202101290S A SG11202101290S A SG 11202101290SA SG 11202101290S A SG11202101290S A SG 11202101290SA SG 11202101290S A SG11202101290S A SG 11202101290SA
- Authority
- SG
- Singapore
- Prior art keywords
- acidaminococcus
- cpf1
- enhance
- cleavage activity
- dna cleavage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862716138P | 2018-08-08 | 2018-08-08 | |
| US201862749607P | 2018-10-23 | 2018-10-23 | |
| US201962870268P | 2019-07-03 | 2019-07-03 | |
| PCT/US2019/045813 WO2020033774A1 (en) | 2018-08-08 | 2019-08-08 | Novel mutations that enhance the dna cleavage activity of acidaminococcus sp. cpf1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202101290SA true SG11202101290SA (en) | 2021-03-30 |
Family
ID=67766344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202101290SA SG11202101290SA (en) | 2018-08-08 | 2019-08-08 | Novel mutations that enhance the dna cleavage activity of acidaminococcus sp. cpf1 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11447758B2 (ko) |
| EP (1) | EP3833750A1 (ko) |
| JP (1) | JP2022503535A (ko) |
| KR (1) | KR20210042130A (ko) |
| CN (1) | CN112912496A (ko) |
| AU (2) | AU2019319230B2 (ko) |
| BR (1) | BR112021002258A2 (ko) |
| CA (1) | CA3108909A1 (ko) |
| IL (1) | IL280680A (ko) |
| MX (1) | MX2021001553A (ko) |
| SG (1) | SG11202101290SA (ko) |
| WO (1) | WO2020033774A1 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US12012433B1 (en) | 2020-02-27 | 2024-06-18 | Integrated Dna Technologies Inc. | Expression and purification of Cas enzymes |
| JP2023524066A (ja) | 2020-05-01 | 2023-06-08 | インテグレーティッド ディーエヌエイ テクノロジーズ インコーポレーティッド | 非カノニカルｔｔｔｔプロトスペーサー隣接モチーフにて増強された切断活性を備えるラクノスピラセｓｐ．のｃａｓ１２ａ変異体 |
| WO2022061748A1 (zh) * | 2020-09-25 | 2022-03-31 | 中国科学院微生物研究所 | 广谱识别PAM序列的FnCpf1突变体及其应用 |
| TW202342756A (zh) | 2022-03-01 | 2023-11-01 | 美商巴斯夫農業解決方案種子美國有限責任公司 | Ｃａｓ１２ａ切口酶 |
| WO2024095245A2 (en) | 2022-11-04 | 2024-05-10 | LifeEDIT Therapeutics, Inc. | Evolved adenine deaminases and rna-guided nuclease fusion proteins with internal insertion sites and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840702B2 (en) | 2014-12-18 | 2017-12-12 | Integrated Dna Technologies, Inc. | CRISPR-based compositions and methods of use |
| JP6914274B2 (ja) * | 2016-01-22 | 2021-08-04 | ザ・ブロード・インスティテュート・インコーポレイテッド | Ｃｒｉｓｐｒｃｐｆ１の結晶構造 |
| US9896696B2 (en) * | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| WO2017189308A1 (en) * | 2016-04-19 | 2017-11-02 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| WO2018035388A1 (en) * | 2016-08-17 | 2018-02-22 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| US11136567B2 (en) * | 2016-11-22 | 2021-10-05 | Integrated Dna Technologies, Inc. | CRISPR/CPF1 systems and methods |
| CN107312761B (zh) * | 2017-07-18 | 2019-07-05 | 江苏溥博生物科技有限公司 | 一种AsCpf1突变体蛋白、编码基因、重组表达载体及其制备方法与应用 |
| EP3765614A1 (en) | 2018-03-14 | 2021-01-20 | Editas Medicine, Inc. | Systems and methods for the treatment of hemoglobinopathies |
-
2019
- 2019-08-08 EP EP19759179.5A patent/EP3833750A1/en active Pending
- 2019-08-08 MX MX2021001553A patent/MX2021001553A/es unknown
- 2019-08-08 BR BR112021002258-9A patent/BR112021002258A2/pt unknown
- 2019-08-08 CN CN201980066143.3A patent/CN112912496A/zh active Pending
- 2019-08-08 AU AU2019319230A patent/AU2019319230B2/en active Active
- 2019-08-08 SG SG11202101290SA patent/SG11202101290SA/en unknown
- 2019-08-08 CA CA3108909A patent/CA3108909A1/en active Pending
- 2019-08-08 WO PCT/US2019/045813 patent/WO2020033774A1/en unknown
- 2019-08-08 KR KR1020217006696A patent/KR20210042130A/ko not_active Application Discontinuation
- 2019-08-08 JP JP2021506705A patent/JP2022503535A/ja active Pending
- 2019-08-08 US US16/536,256 patent/US11447758B2/en active Active
-
2021
- 2021-02-07 IL IL280680A patent/IL280680A/en unknown
-
2022
- 2022-07-26 US US17/873,485 patent/US20230138679A1/en active Pending
-
2024
- 2024-03-05 AU AU2024201449A patent/AU2024201449A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210042130A (ko) | 2021-04-16 |
| CA3108909A1 (en) | 2020-02-13 |
| US20230138679A1 (en) | 2023-05-04 |
| US11447758B2 (en) | 2022-09-20 |
| WO2020033774A1 (en) | 2020-02-13 |
| AU2019319230A1 (en) | 2021-03-18 |
| JP2022503535A (ja) | 2022-01-12 |
| AU2024201449A1 (en) | 2024-03-21 |
| AU2019319230B2 (en) | 2024-03-21 |
| BR112021002258A2 (pt) | 2021-05-04 |
| US20200109382A1 (en) | 2020-04-09 |
| IL280680A (en) | 2021-03-25 |
| CN112912496A (zh) | 2021-06-04 |
| EP3833750A1 (en) | 2021-06-16 |
| MX2021001553A (es) | 2021-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280680A (en) | New mutations that enhance DNA cleavage activity of ACIDAMINOCOCCUS SP. CPF1 | |
| DK3911354T3 (da) | AVV-formidlet genterapi, der genskaber otoferlin-genet | |
| IL279685A (en) | Gene therapy | |
| LT3612237T (lt) | Genų terapija | |
| GB201907242D0 (en) | Dna methods etc ii | |
| EP3619311C0 (en) | DNA ARRANGEMENT | |
| IL279584A (en) | Combined gene therapy | |
| GB201904004D0 (en) | Photocatalyst | |
| GB201812474D0 (en) | Nucleic acid construct | |
| GB201905301D0 (en) | Gene therapy | |
| GB201817470D0 (en) | Gene therapy | |
| GB201802326D0 (en) | Gene therapy | |
| GB201813439D0 (en) | Novel catalytic materials | |
| EP3634598A4 (en) | DEMULGATOR OR WATER PURIFIER ACTIVITY MODIFICATORS | |
| IL285396A (en) | Biological flooring | |
| GB201701968D0 (en) | Gene therapy | |
| GB201904653D0 (en) | Universal DNA assembly | |
| EP3760209C0 (en) | GENE THERAPY SPECIFIC TO THE SITE OF AN ISCHEMIC INJURY | |
| SG11202009814VA (en) | Dna construct design system | |
| GB201811540D0 (en) | Gaucher gene therapy | |
| GB201820982D0 (en) | Gene Therapy | |
| GB201811541D0 (en) | Gene therapy | |
| GB202110833D0 (en) | DNA on the pastport | |
| GB201801511D0 (en) | Gene therapy | |
| GB201910724D0 (en) | Cycloadition reactions |